Fundraising Fox

Ironwood Pharmaceuticals

Cambridge, US · Delaware corporation · 6 known investors

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.

BiotechDigital HealthHealthtech

Founders & leadership

PM
PETER M. HECHTFounder
MG
MARK G. CURRIEExecutive
HE
HALLEY E. GIBLERTExecutive
TG
THOMAS GRANEYExecutive
TA
THOMAS A. MCCOURTExecutive

Board

TG
TERRANCE G. MCGUIREBoard director
LS
LAWRENCE S. OLANOFFBoard director
EP
EDWARD P. OWENSBoard director
JM
JULIE MCHUGHBoard director
MH
MARSHA H. FANUCCIBoard director
DE
DOUGLAS E. WILLIAMSBoard director
CT
CHRISTOPHER T. WALSHBoard director

Investors · 6

F-Prime CapitalCambridge · $3M – $10M
Mountain Group CapitalNashville
Ridgeback CapitalMiami
VenrockPalo Alto · $500K – $10M
Maverick VenturesreportedSan Francisco · $3M – $10M
Polaris PartnersreportedBoston · $500K – $5M

Reported raises · per SEC filings

Form D private placements

$150M disclosed across 1 round · 2016

▶$150MraisedOct 2016 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • LAWRENCE S. OLANOFFDirector
  • TERRANCE G. MCGUIREDirector
  • MARK G. CURRIEExecutive Officer
  • EDWARD P. OWENSDirector
  • JULIE MCHUGHDirector
  • HALLEY E. GIBLERTExecutive Officer
  • PETER M. HECHTExecutive Officer, Director
  • MARSHA H. FANUCCIDirector
  • THOMAS GRANEYExecutive Officer
  • DOUGLAS E. WILLIAMSDirector
  • CHRISTOPHER T. WALSHDirector
  • THOMAS A. MCCOURTExecutive Officer
  • ANDREW DREYFUSDirector
Offering amount
$150M
Amount sold
$150M
Sales commissions
$20K
Finders' fees
$20K
Placement agents
J. WOOD CAPITAL ADVISORS
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Medscape169 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Ironwood Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Dimensional Fund Advisors LP Raises Holdings in Ironwood Pharmaceuticals, Inc. $IRWDmarketbeat.com · Aug 2026Ironwood Pharmaceuticals’ Earnings Call Highlights LINZESS Surge - TipRanks.comtipranks.com · Aug 2026Ironwood Pharmaceuticals (Nasdaq: IRWD) boosts 2026 guidance after strong Q2stocktitan.net · Aug 2026Press Release: Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Resultsmoomoo.com · Aug 2026Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results - BioSpacebiospace.com · Aug 2026Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Resultsfinance.yahoo.com · Aug 2026

Frequently asked questions

What does Ironwood Pharmaceuticals do?
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.
Who founded Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals was founded by PETER M. HECHT.
Who are Ironwood Pharmaceuticals's investors?
Ironwood Pharmaceuticals's investors include F-Prime Capital, Mountain Group Capital, Ridgeback Capital, Venrock, Maverick Ventures, Polaris Partners.
How much funding has Ironwood Pharmaceuticals raised?
Ironwood Pharmaceuticals has disclosed $150M raised across 1 round.
Where is Ironwood Pharmaceuticals headquartered?
Ironwood Pharmaceuticals is headquartered in Cambridge, US.